Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Nature Medicine 13, 269 (1 March 2007) | doi:10.1038/nm0307-269;
Health agency pulls back on 'patronizing' approach to TB treatment
Abstract
For more than a decade, the World Health Organization (WHO) has relied on Direct Observed Therapy Short-course, or DOTS, to fight tuberculosis (TB)—and for nearly as long, the strategy has been controversial. The idea behind DOTS is that a healthcare worker should directly observe those infected swallow the TB drugs at least for the first two months of the six-month therapy.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
